PV QA 2 - Poster Viewing Q&A 2
10/22/2018
10:45 AM - 12:15 PM
Location: Innovation Hub, Exhibit Hall 3
Session Type: PosterViewingQ&A
Presentations:
10:45 AM - 12:15 PM
Long-term Outcome of Sensorineural and Conductive Hearing Loss Following Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_38_2893
10:45 AM - 12:15 PM
5-Fu Continuously Pump Infusion Via Superficial Temporal Artery Cannula for High T Staged Nasopharyngeal Carcinoma: A Phase I Clinical Trial
Poster Presenter:
Presentation No : MO_33_2772
10:45 AM - 12:15 PM
A Contour-Based Approach for Predicting Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Therapy
Poster Presenter:
Presentation No : MO_9_2696
10:45 AM - 12:15 PM
A Learning-Based Method to Improve Pelvis Cone Beam CT Image Quality for Prostate Cancer Radiation Therapy
Poster Presenter: – Emory University
Presentation No : MO_19_2880
10:45 AM - 12:15 PM
A Multicenter Prospective Cohort Study Evaluating Quality of Life after Radiation or Surgery for Potentially Unstable Spinal Metastases
Poster Presenter: – Sunnybrook Health Sciences Centre
Presentation No : MO_9_2681
10:45 AM - 12:15 PM
A new Radiation concept ,Treatment of Squamous Cell Carcinoma by Alpha-radiation based Brachytherapy (Alpha DaRT)
Poster Presenter:
Presentation No : MO_27_2643
10:45 AM - 12:15 PM
A Novel Fractionated Regimen Using Stereotactic Radiosurgery for Trigeminal Neuralgia
Poster Presenter:
Presentation No : MO_4_2549
10:45 AM - 12:15 PM
A Novel Three Dimensional Conformal Radiation Therapy Technique to Decrease the Mean Parotid Gland Dose in Whole Brain Radiation Therapy
Poster Presenter:
Presentation No : MO_5_2578
10:45 AM - 12:15 PM
A Phase II Prospective Study about the Efficacy and Toxicity of the Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy Followed With the Capecitabine Metronomic Chemotherapy
Poster Presenter: – Si Chuan Cancer Hospital
Presentation No : MO_26_2613
10:45 AM - 12:15 PM
A Pilot Trial Assessing Apatinib in Advanced Head and Neck Squamous Cell Carcinoma That Failed in Previous Standard Chemotherapy or Chemoradiotherapy
Poster Presenter:
Presentation No : MO_37_2861
10:45 AM - 12:15 PM
A Pilot/Phase II Study of Stereotactic Radiosurgery for Brain Metastases Using Rational Dose Selection
Poster Presenter: – Yale University
Presentation No : MO_16_2869
10:45 AM - 12:15 PM
A Population-Based Study of Melanoma Brain Metastasis Treatment: Has Progress in Systemic Therapy and Radiation Therapy Improved Patient Outcomes?
Poster Presenter:
Presentation No : MO_1_2481
10:45 AM - 12:15 PM
A Population-Based Study of Neoplastic Mast Cell Disease
Poster Presenter: – University of Rochester
Presentation No : MO_44_2544
10:45 AM - 12:15 PM
A Proposal of N Classification Based on Quantitative Metastatic Lymph Node Regions in Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_38_2892
10:45 AM - 12:15 PM
A Prospective Analysis of Ototoxicity in Modern Radiation Therapy Treatments for Head and Neck Squamous Cell Carcinoma (HNSCC) Patients Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Tri-weekly Cisplatin (Cis)
Poster Presenter:
Presentation No : MO_40_2543
10:45 AM - 12:15 PM
A Radiomics Signature for Treatment Stratification in Advanced and Recurrent Nasopharynx Cancer
Poster Presenter:
Presentation No : MO_33_2763
10:45 AM - 12:15 PM
A Retrospective Review on Stereotactic Radiosurgery Cases Planned with Dynamic Conformal Arcs Versus Volumetric Modulated Arc Therapy
Poster Presenter:
Presentation No : MO_2_2497
10:45 AM - 12:15 PM
A Retrospective Study of 3D-CRT/IMRT and Concomitant Intra-arterial Chemotherapy for Maxillary Sinus Carcinoma
Poster Presenter:
Presentation No : MO_39_2524
10:45 AM - 12:15 PM
A Simplified Three-Isocenter VMAT for Craniospinal Irradiation
Poster Presenter: – Hiroshima University
Presentation No : MO_44_2832
10:45 AM - 12:15 PM
A Single Institution Retrospective Analysis of Adult Head & Neck Rhabdomyosarcoma (HN RMS) from 1984-2017
Poster Presenter:
Presentation No : MO_20_2588
10:45 AM - 12:15 PM
A Single-Centre Prospective Assessment of Mask Versus Frame Fixation during Gamma Knife Treatment for Brain Metastases
Poster Presenter:
Presentation No : MO_3_2521
10:45 AM - 12:15 PM
A Web-Based Application That Makes Radiation Therapy Plans and Treatment Details Readily Accessible to Multidisciplinary Care Teams
Poster Presenter:
Presentation No : MO_19_2844
10:45 AM - 12:15 PM
Adaptive IMRT Planning Improves Pharyngeal Sparing for Oropharyngeal Cancer
Poster Presenter: – Duke University Medical Center
Presentation No : MO_29_2679
10:45 AM - 12:15 PM
ADARO: A smartphone-based interactive contouring atlas for the irradiation of head and neck carcinoma.
Poster Presenter:
Presentation No : MO_21_2659
10:45 AM - 12:15 PM
Adjuvant External Beam Radiation Therapy for Surgically Resected, Non-Metastatic Anaplastic Thyroid Cancer
Poster Presenter:
Presentation No : MO_29_2680
10:45 AM - 12:15 PM
Adjuvant Regional Nodal Radiation in Sentinel Lymph Node Positive Merkel Cell Carcinoma without Completion Lymph Node Dissection
Poster Presenter:
Presentation No : MO_21_2466
10:45 AM - 12:15 PM
Adoption of AJCC 8th Edition for p16+ Oropharynx Cancers May Result in Decreased Utilization of Adjuvant Therapies Due to Shifts in Pathologic Nodal Staging
Poster Presenter:
Presentation No : MO_31_2731
10:45 AM - 12:15 PM
Adverse Events and Patient Reported Outcomes from Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma in the Involved Site Era
Poster Presenter:
Presentation No : MO_43_2720
10:45 AM - 12:15 PM
Adverse Radiation Effect and Disease Control in Patients Undergoing Concurrent Stereotactic Radiosurgery and Immunotherapy for Brain Metastases
Poster Presenter:
Presentation No : MO_8_2645
10:45 AM - 12:15 PM
An NCDB Analysis Investigating Outcomes in HPV Negative Oropharyngeal Carcinoma - An Attempt to Bridge the Gap Due to Lack of Accrual in RTOG 1221
Poster Presenter: – University of Toledo
Presentation No : MO_39_2511
10:45 AM - 12:15 PM
Analyzing the Impact of Primary Tumor PET Metrics and Clinical Features on Outcomes in Locally Advanced Sinonasal Malignancy
Poster Presenter:
Presentation No : MO_32_2754
10:45 AM - 12:15 PM
Angiosarcoma: History of Prior Radiation Therapy is an Adverse Prognostic Factor
Poster Presenter:
Presentation No : MO_22_2513
10:45 AM - 12:15 PM
Apatinib Plus Radiation Therapy or Not in Chemotherapy-Refractory Recurrent or Metastatic Oral Squamous Cell Carcinoma: A Pilot Study
Poster Presenter:
Presentation No : MO_35_2836
10:45 AM - 12:15 PM
App-based PRO monitoring in geriatric patients undergoing radiation therapy - an initial analysis of the prospective TeleGraPH trial.
Poster Presenter:
Presentation No : MO_17_2595
10:45 AM - 12:15 PM
Assessing the Association between Tumor Location and Toxicity Outcomes after Stereotactic Radiosurgery for Brain Metastases
Poster Presenter:
Presentation No : MO_15_2850
10:45 AM - 12:15 PM
Assessing the Impact of Pre-Treatment White Matter Hyperintensities on Cognitive Function After Whole Brain Radiation Therapy (WBRT)
Poster Presenter:
Presentation No : MO_1_2487
10:45 AM - 12:15 PM
Assessment of Interrater Reliability for Comorbidity Indices in Determining Eligibility for Treatment Intensification in Head and Neck Cancer
Poster Presenter:
Presentation No : MO_23_2463
10:45 AM - 12:15 PM
Association Between Radiation Dose and Ureteral Strictures in the Treatment of Retroperitoneal Sarcoma
Poster Presenter:
Presentation No : MO_21_2480
10:45 AM - 12:15 PM
Atypical histopathological features and the risk of progression/recurrence in WHO grade I-II meningiomas
Poster Presenter: – Massachusetts General Hospital
Presentation No : MO_3_2530
10:45 AM - 12:15 PM
Automatic Contour Propagation of Organs-at-Risk on Serial MRIs and Dosimetric Implications in Glioblastoma Patients Undergoing Chemo-Radiation
Poster Presenter:
Presentation No : MO_14_2813
10:45 AM - 12:15 PM
Automatic Prostate Segmentation using Deep Learning and MR Images
Poster Presenter:
Presentation No : MO_19_2885
10:45 AM - 12:15 PM
Bi-institutional report on consolidative proton therapy after initial chemotherapy for mediastinal diffuse large B-cell and primary mediastinal large B-cell lymphomas
Poster Presenter: – University of Pennsylvania
Presentation No : MO_43_2816
10:45 AM - 12:15 PM
Bilateral Elective Nodal Radiation Increases Narcotic Requirement But Not Patient-Reported Pain During Head and Neck Cancer Radioation Therapy
Poster Presenter:
Presentation No : MO_24_2575
10:45 AM - 12:15 PM
Bone Event: A New Surrogate to Solitary Plasmacytoma
Poster Presenter:
Presentation No : MO_42_2708
10:45 AM - 12:15 PM
Cancer Genetic Markers According to Radiotherapeutic Response in Patients with Glioblastoma - Radiogenomic Approach for Precision Medicine
Poster Presenter:
Presentation No : MO_16_2878
10:45 AM - 12:15 PM
Challenging the Requirement to Treat the Contralateral Neck with >4 -Mm Tumor Thickness in Patients Receiving Postoperative Radiation Therapy for Squamous Cell Carcinoma of the Oral Tongue or Floor of Mouth
Poster Presenter:
Presentation No : MO_27_2653
10:45 AM - 12:15 PM
Chemoradiation or Altered Fractionation for T2N0M0 Glottic Cancer
Poster Presenter:
Presentation No : MO_27_2471
10:45 AM - 12:15 PM
Cisplatin or Carboplatin-Based Chemoradiation for Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck: A Population-Based Comparison
Poster Presenter:
Presentation No : MO_37_2866
10:45 AM - 12:15 PM
Clinical Outcome After Multimodality Approach Including Radiation Therapy in Rhabdomyosarcoma: Single-Institution Experience
Poster Presenter:
Presentation No : MO_21_2660
10:45 AM - 12:15 PM
Clinical Outcome of Brainstem Glioma Treated With or Without Concurrent Chemoradiotherapy: An Institutional Retrospective Analysis of 71 Patients
Poster Presenter:
Presentation No : MO_12_2761
10:45 AM - 12:15 PM
Clinical Outcomes and Safety Profile of Salvage External Beam Radiation Therapy and Re-Irradiation for Recurrent Atypical Meningioma
Poster Presenter:
Presentation No : MO_2_2492
10:45 AM - 12:15 PM
Clinical Outcomes for Primary Parenchymal Tumor of Intermediate Differentiation
Poster Presenter: – Kaiser Permanente Los Angeles Medical Center
Presentation No : MO_6_2619
10:45 AM - 12:15 PM
Clinical Outcomes of Reirradiation in IDH-mutant Astrocytomas and 1p/19q Codeleted Oligodendrogliomas
Poster Presenter:
Presentation No : MO_5_2799
10:45 AM - 12:15 PM
Clinical, Dosimetric, and Radiographic Predictors of Local Failure Following Stereotactic Radiosurgery for Melanoma Brain Metastases
Poster Presenter:
Presentation No : MO_9_2707
10:45 AM - 12:15 PM
Cognitive-Linguistic Deficits Following Treatment of Brain Tumors: Results of a Prospective Pilot Study
Poster Presenter:
Presentation No : MO_15_2834
10:45 AM - 12:15 PM
Comparative Utilization Analysis of Radiation Modalities Among Adults with Primary Brain Tumors in the United States from 2004 to 2015
Poster Presenter:
Presentation No : MO_14_2819
10:45 AM - 12:15 PM
Comparing Incidence of Cataract Formation in Lens-Sparing Versus Whole-Eye Irradiation in Patients with Retinoblastoma
Poster Presenter:
Presentation No : MO_35_2811
10:45 AM - 12:15 PM
Comparison of Local Failure and Radionecrosis According to Dose Prescription for Small to Medium Sized Brain Metastasis treated with Radiosurgery
Poster Presenter:
Presentation No : MO_12_2786
10:45 AM - 12:15 PM
Comparison of the Clinical Behaviour of N3 HPV Related and Unrelated Head and Neck Cancer in the IMRT era
Poster Presenter:
Presentation No : MO_34_2808
10:45 AM - 12:15 PM
Comparison of Treatment Modalities for Large Brain Metastases
Poster Presenter:
Presentation No : MO_4_2558
10:45 AM - 12:15 PM
Concurrent Immunotherapy Usage and Asymmetric Growth May Distinguish True Progression from Treatment Effect in Growing Brain Metastases after Stereotactic Radiosurgery
Poster Presenter:
Presentation No : MO_8_2676
10:45 AM - 12:15 PM
Concurrent Radiation and Biological Therapy is Safe in Multiple Myeloma
Poster Presenter:
Presentation No : MO_43_2798
10:45 AM - 12:15 PM
Condensed Low Dose Total Skin Electron Beam Therapy for Mycosis Fungoides: A Single Institution Experience
Poster Presenter:
Presentation No : MO_43_2734
10:45 AM - 12:15 PM
Consensus Guidelines for Target Volume Definition of the Sacrum in Spinal Stereotactic Body Radiation Therapy (SBRT)
Poster Presenter:
Presentation No : MO_2_2503
10:45 AM - 12:15 PM
Consensus Radiation Therapy Contouring Guidelines for Glioblastoma, Based on NRG Recommendations
Poster Presenter: – Northwestern Memorial Hospital
Presentation No : MO_14_2818
10:45 AM - 12:15 PM
Consolidative Radiation Therapy (RT) for advanced stage Hodgkin's Lymphoma (HL) May Improve Progression Free Survival Than ABVD Alone for Adult Patients.
Poster Presenter:
Presentation No : MO_42_2655
10:45 AM - 12:15 PM
Correlation of Magnetic Resonance Imaging Apparent Diffusion Coeffecient Values with Treatment Outcome in High Grade Glioma Patients Undergoing Concurrent Chemoradiation
Poster Presenter:
Presentation No : MO_9_2703
10:45 AM - 12:15 PM
Curability of Radiotherapy in Elderly Patients With Early-stage Extranodal Nasal-type NK/T-cell Lymphoma: A Multicenter Study from the China Lymphoma Collaborative Group (CLCG)
Poster Presenter:
Presentation No : MO_41_2553
10:45 AM - 12:15 PM
Daily Tracking with MRI-Guided Radiation Therapy of Glioblastoma Resection Cavity and Cerebral Edema Volumes
Poster Presenter:
Presentation No : MO_10_2712
10:45 AM - 12:15 PM
Decreased Frequency of MGMT Promoter Hypermethylation in Locally Relapsed Versus Locally Controlled p16 Negative Head and Neck Squamous Cell Carcinoma Patients After Chemoradiotherapy
Poster Presenter:
Presentation No : MO_40_2537
10:45 AM - 12:15 PM
Decreasing Utilization of Concurrent Chemotherapy in Human Papillomavirus-Positive Oropharyngeal Cancer: Analysis of National Patterns of Care
Poster Presenter:
Presentation No : MO_33_2770
10:45 AM - 12:15 PM
Deep Learning-Based Pseudo CT Reconstruction for MR Only-Guided Radiation Therapy of Lung SBRT
Poster Presenter:
Presentation No : MO_18_2725
10:45 AM - 12:15 PM
Defining an Intermediate Risk Group for Low Grade Glioma. An Analysis of the National Cancer Database
Poster Presenter: – Yale-New Haven Hospital
Presentation No : MO_5_2584
10:45 AM - 12:15 PM
Definitive HDR Brachytherapy for Non-Melanomatous Skin Cancers: an Effective and Efficient Cure
Poster Presenter: – Loyola University Medical Center
Presentation No : MO_24_2576
10:45 AM - 12:15 PM
Definitive Treatment of a Risky Region: The Efficacy and Toxicities of High Dose Rate Brachytherapy for Non-Melanomatous Skin Cancers of the Extremities
Poster Presenter:
Presentation No : MO_21_2739
10:45 AM - 12:15 PM
Determinants of Idiopathic Pneumonia Syndrome in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Transplantation with Total Body Irradiation-Based Myeloablative Conditioning
Poster Presenter: – University of Minnesota
Presentation No : MO_44_2517
10:45 AM - 12:15 PM
Development and Validation of A Deep Learning Algorithm for Automated Delineation of Primary Tumor for Nasopharyngeal Carcinoma from Multimodal Magnetic Resonance Images
Poster Presenter:
Presentation No : MO_33_2773
10:45 AM - 12:15 PM
Development of Temporal Dose-weighted Positron Emission Tomography Metabolic Imaging Biomarkers (PET MIBs) of Radiation-related Parotid Glands Injury in Oropharyngeal Cancer Patients
Poster Presenter:
Presentation No : MO_24_2562
10:45 AM - 12:15 PM
Diffusion-Weighted MRI As an Early Biomarker of Xerostomia in Oropharyngeal Cancer Patients Treated with Radiation Therapy
Poster Presenter:
Presentation No : MO_39_2504
10:45 AM - 12:15 PM
Disparities in Follow-Up Care After Definitive Treatment for Head and Neck Cancer in an Ethnically Diverse Population
Poster Presenter:
Presentation No : MO_34_2793
10:45 AM - 12:15 PM
Do Tumor PD-L1 Expression and Neutrophil to Lymphocyte Ratio Influence the Efficacy of Stereotactic Radiosurgery for Brain Metastases from Non-Small Cell Lung Cancer?
Poster Presenter:
Presentation No : MO_12_2760
10:45 AM - 12:15 PM
Dose-Reduced Stereotactic Radiosurgery for Brain Metastases in the Era of CNS-Penetrating Systemic Therapies
Poster Presenter:
Presentation No : MO_5_2580
10:45 AM - 12:15 PM
Dose-Volume Histogram (DVH) Patterns within the Salivary Glands and Clinical Parameters Predict Xerostomia in Head and Neck Cancer (HNC) Patients, from Injury to Recovery
Poster Presenter:
Presentation No : MO_39_2523
10:45 AM - 12:15 PM
Dosimetric Comparison of COMS and Circular Eye Physics Plaques to Treat Uveal Melanoma
Poster Presenter:
Presentation No : MO_26_2611
10:45 AM - 12:15 PM
Dosimetric Comparison of Volumetric Modulated Arc Therapy Versus 3-Dimensional Conformal Radiation Therapy in Post-Operative Patients of High Grade Glioma
Poster Presenter:
Presentation No : MO_9_2684
10:45 AM - 12:15 PM
Dosimetric Impact of Cesium 131 Seed Migration in Collagen Carrier Brain Brachytherapy Implants
Poster Presenter:
Presentation No : MO_11_2727
10:45 AM - 12:15 PM
Dosimetric Influences and Reproducibility of Flexed Neck and Extended Neck Set-up Positions in Helical Tomotherapy of Nasopharyngeal Carcinoma.
Poster Presenter:
Presentation No : MO_32_2757
10:45 AM - 12:15 PM
Early Metabolic Response at Mid-Radiation Therapy FDG-PET Imaging Predicts Patterns of Treatment Failure in Locally Advanced Oropharyngeal Cancer
Poster Presenter:
Presentation No : MO_30_2699
10:45 AM - 12:15 PM
Early Objective Response as a Prognosticator for Final Objective Response and Survival following SRS for Brain Metastases Treated with Concurrent Systemic Therapy
Poster Presenter: – Case Western Reserve University School of Medicine
Presentation No : MO_10_2715
10:45 AM - 12:15 PM
Early-Stage Extranodal NK/T-cell Lymphoma: A Role for Elective Nodal Irradiation?
Poster Presenter: – MD Anderson Cancer Center
Presentation No : MO_42_2687
10:45 AM - 12:15 PM
Edema or Margin in Glioblastoma CTV Impact on Pattern of Recurrence and Survival of Two Different CTV Delineations Independently Peer Reviewed.
Poster Presenter:
Presentation No : MO_8_2651
10:45 AM - 12:15 PM
Effect of Feeding Tube Strategy on Hospitalization Rates and Outcomes in Head and Neck Cancer Patients Treated With Chemoradiotherapy
Poster Presenter:
Presentation No : MO_25_2585
10:45 AM - 12:15 PM
Effect of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy on Nutritional Status in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Prospective Observational Study
Poster Presenter:
Presentation No : MO_34_2782
10:45 AM - 12:15 PM
Effect of nutritional supplement in patients with local advanced nasopharyngeal carcinoma receiving definitive radio-chemotherapy: a prospective, randomized, controlled trial(NCT02948699)
Poster Presenter:
Presentation No : MO_24_2581
10:45 AM - 12:15 PM
Effect of Whole Brain Radiation Therapy on the Absolute Brain Volume Loss
Poster Presenter:
Presentation No : MO_13_2792
10:45 AM - 12:15 PM
Effectiveness of Repeat Courses of Stereotactic Radiosurgery in Patients with Brain Metastases: A Single Institution Experience
Poster Presenter:
Presentation No : MO_13_2801
10:45 AM - 12:15 PM
Efficacy and Safety of Hypofractionated Stereotactic Radiosurgery for Perioptic Lesions
Poster Presenter:
Presentation No : MO_11_2735
10:45 AM - 12:15 PM
Efficacy of Palliative Radiation Therapy (RT) for Diffuse Large B-Cell Lymphoma: A Population-Based Retrospective Review
Poster Presenter:
Presentation No : MO_44_2851
10:45 AM - 12:15 PM
Efficacy of Proton Beam Radiation Therapy and Chemotherapy in Patients with Ewing Sarcoma Family of Tumors of the Trunk.
Poster Presenter:
Presentation No : MO_21_2673
10:45 AM - 12:15 PM
Efficacy of SBRT for Local Control in Recurrent and Metastatic Sarcoma
Poster Presenter:
Presentation No : MO_20_2607
10:45 AM - 12:15 PM
Elderly patients: NBTXR3 as a novel treatment option in locally advanced HNSCC
Poster Presenter:
Presentation No : MO_23_2547
10:45 AM - 12:15 PM
Elucidation of an Exquisite Synergistic Interaction Between ATR Inhibitors and Alkylating Agents in MGMT-Methylated Glioma cells
Poster Presenter:
Presentation No : MO_4_2531
10:45 AM - 12:15 PM
Endocrine Remission after Pituitary Stereotactic Radiosurgery:Differences in Rates of Response for Matched Cohorts of Cushing's Disease and Acromegaly Patients
Poster Presenter:
Presentation No : MO_15_2827
10:45 AM - 12:15 PM
Estimated Increase in Mean Lifetime Survival for Glioblastoma Patients Age 65 Years and Older Treated with Tumor Treating Fields and Temozolomide Compared to Patients Treated with Temozolomide Alone
Poster Presenter:
Presentation No : MO_5_2572
10:45 AM - 12:15 PM
Estimating Quality of Life Variation using BLE wearable devices on Android based architecture
Poster Presenter:
Presentation No : MO_18_2670
10:45 AM - 12:15 PM
Evaluating Nationwide Practice Patterns in Chemoradiotherapeutic Regimens and Relative Efficacy of Chemoradiation Versus Adjuvant Radiation for Grade III Gliomas
Poster Presenter:
Presentation No : MO_13_2805
10:45 AM - 12:15 PM
Evaluation of a Novel Atlas to Reduce Variability of Contouring Masticatory Muscles in Head and Neck Cancer Patients.
Poster Presenter:
Presentation No : MO_26_2614
10:45 AM - 12:15 PM
Evaluation of Induction Chemotherapy with EPF or TPF for Patients with Locally Advanced Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_31_2728
10:45 AM - 12:15 PM
Evaluation of Interim PET CT Scan As Predictor for Early Response to Chemoradiotherapy in Locally Advanced Head and Neck Cancer Retrospective Study
Poster Presenter:
Presentation No : MO_28_2654
10:45 AM - 12:15 PM
Evaluation of Larynx Preservation on Patients With Locally Advanced Laryngeal Cancer in the Era of IMRT: Results from a Single Tertiary Cancer Center
Poster Presenter:
Presentation No : MO_40_2546
10:45 AM - 12:15 PM
Evolution in the Role of Stereotactic Radiosurgery in Patients with Multiple Brain Metastases: An International Survey
Poster Presenter:
Presentation No : MO_6_2602
10:45 AM - 12:15 PM
Evolving National Practice Patterns of Hypofractionated Stereotactic Radiation Therapy Versus Single-Fraction Radiosurgery for Brain Metastases
Poster Presenter: – Yale-New Haven Hospital
Presentation No : MO_4_2532
10:45 AM - 12:15 PM
Examining Computerized Neurocognitive Screening Test in Predicting Cerebral Progression Free Survival in Patients Undergoing Brain Stereotactic Radiation Therapy for Brain Metastases: A Pilot Study
Poster Presenter:
Presentation No : MO_13_2800
10:45 AM - 12:15 PM
Examining the Incidence of HPV Positive Oropharynx Cancer in an Ethnically Diverse Population
Poster Presenter:
Presentation No : MO_34_2795
10:45 AM - 12:15 PM
Exploratory Dosimetric Study of the Impact of the Pre-Radiation Therapy Intra Tumoral Injection of Hafnium Oxide Nanoparticles Along the Radiation Treatment of Extremity and Trunk Wall Soft Tissue Sarcomas.
Poster Presenter:
Presentation No : MO_20_2596
10:45 AM - 12:15 PM
Extent of Resection Is Potent Prognostic Factor Next to Molecular Pathologic Subtype in Low-Grade Glioma
Poster Presenter:
Presentation No : MO_2_2493
10:45 AM - 12:15 PM
Failure Patterns of Distant Metastasis after Intensity-Modulated Radiation Therapy in Patients With Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_26_2628
10:45 AM - 12:15 PM
FDG-PET Imaging-derived Radiomics Correlates of Human Papilloma Virus status: Connecting the Dots in the Oropharyngeal Cancer Biology, Metabolism, and Imaging Interplay
Poster Presenter:
Presentation No : MO_24_2612
10:45 AM - 12:15 PM
Feasibility of a Risk-Adapted Approach to Whole Brain Radiation Therapy
Poster Presenter:
Presentation No : MO_16_2875
10:45 AM - 12:15 PM
Feasibility of Hippocampal Dose-volume Parameters Associated with Memory Decline in Volumetric Modulated Arc Therapy for Supratentorial Tumors
Poster Presenter:
Presentation No : MO_15_2854
10:45 AM - 12:15 PM
Gemcitabine based induction chemotherapy may improve the survival of stage IVA nasopharyngeal carcinoma
Poster Presenter:
Presentation No : MO_28_2664
10:45 AM - 12:15 PM
Genomic Copy Number Gains of ErbB Family Members Predict Poor Clinical Outcomes in Glioma Patients
Poster Presenter:
Presentation No : MO_11_2729
10:45 AM - 12:15 PM
Geometric variations of the clinical target volume in neck sublocations for image-guided radiation therapy of nasopharyngeal cancer
Poster Presenter:
Presentation No : MO_35_2826
10:45 AM - 12:15 PM
Google Search Trends in Oncology and the Impact of Celebrity Cancer Awareness
Poster Presenter:
Presentation No : MO_17_2633
10:45 AM - 12:15 PM
Helical Tomotherapy for Whole- Brain Irradiation With Integrated Boost to Multiple Brain Metastases: Dosimetric Analysis and Clinical Outcomes
Poster Presenter:
Presentation No : MO_8_2668
10:45 AM - 12:15 PM
Hemophagocytic Syndrome in Early Stage extranodal Natural Killer/T-Cell Lymphoma, nasal type
Poster Presenter:
Presentation No : MO_41_2552
10:45 AM - 12:15 PM
HER2 Status and Long Term Local Control Following SRS for Breast Cancer Brain Metastases
Poster Presenter:
Presentation No : MO_7_2629
10:45 AM - 12:15 PM
Heterogeneity of Treatment Effect: Radiation Therapy for Graves Orbitopathy and Compressive Optic Neuropathy
Poster Presenter:
Presentation No : MO_32_2747
10:45 AM - 12:15 PM
High PD-L1 expression predicts metastasis in nasopharyngeal carcinoma
Poster Presenter:
Presentation No : MO_33_2774
10:45 AM - 12:15 PM
High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases
Poster Presenter: – Memorial Sloan Kettering Cancer Center
Presentation No : MO_4_2548
10:45 AM - 12:15 PM
Higher Volume Facilities are Associated With the Delivery of Lower Dose Radiation Therapy in the Treatment of Cutaneous T-Cell Lymphoma
Poster Presenter:
Presentation No : MO_43_2783
10:45 AM - 12:15 PM
Hippocampal avoidance in Whole Brain Radiation Therapy for Metastases - Comparative Neurocognitive and Dosimetric Assessment
Poster Presenter:
Presentation No : MO_8_2674
10:45 AM - 12:15 PM
Hippocampal sparing preserves neurocognitive functions in patients of Pituitary adenoma treated with IG-IMRT technique.
Poster Presenter:
Presentation No : MO_3_2514
10:45 AM - 12:15 PM
HPV-associated Oropharyngeal Cancer Among Elderly Patients: Dramatically Increased Prevalence and Clinical Implications
Poster Presenter:
Presentation No : MO_28_2666
10:45 AM - 12:15 PM
Human papillomavirus-associated squamous cell carcinoma of the larynx: a retrospective analysis of incidence and clinical outcomes
Poster Presenter: – Wake Forest Baptist Medical Center
Presentation No : MO_25_2582
10:45 AM - 12:15 PM
Hypofractionated Radiation Therapy for Anaplastic Thyroid Carcinoma: 15 Years of Experience in a Single Institution
Poster Presenter:
Presentation No : MO_36_2853
10:45 AM - 12:15 PM
Immunohistochemistry Panel And Treatment Results of p16-negative Head And Neck Cancer: p53 Expression Level Correlated With More Second Primary Cancer.
Poster Presenter:
Presentation No : MO_24_2565
10:45 AM - 12:15 PM
Impact of AJCC 8th Ed. Clinical T- and N-Classifications on Oncologic Outcomes and Patterns of Failure in HPV-Related Oropharyngeal Carcinoma
Poster Presenter: – University of Michigan
Presentation No : MO_24_2573
10:45 AM - 12:15 PM
Impact of Chemotherapy Regimen on Treatment Outcomes in Patients with HPV-associated Oropharyngeal Squamous Cell Carcinoma with Clinical T4 Disease
Poster Presenter: – Kaiser Permanente Los Angeles Medical Center
Presentation No : MO_40_2542
10:45 AM - 12:15 PM
Impact of Corticosteroid Use During Chemoradiotherapy on Lymphopenia and Survival of Glioblastoma Patients
Poster Presenter: – Washington University School of Medicine Department of Radiation Oncology
Presentation No : MO_3_2529
10:45 AM - 12:15 PM
Impact of Diabetes Mellitus and Metformin on Clinical Outcomes of Brain Metastasis Patients Treated With Stereotactic Radiosurgery
Poster Presenter:
Presentation No : MO_12_2768
10:45 AM - 12:15 PM
Impact of Distance from Isocenter on Local Control when utilizing Single Isocenter Frameless VMAT SRS for Intact Brain Metastases
Poster Presenter: – University of Alabama Birmingham
Presentation No : MO_8_2671
10:45 AM - 12:15 PM
Impact of HIV Status on Treatment Outcomes in Head and Neck Cancer
Poster Presenter:
Presentation No : MO_28_2672
10:45 AM - 12:15 PM
Impact of Obesity on Outcomes for Patients with Head/Neck Cancer
Poster Presenter:
Presentation No : MO_39_2577
10:45 AM - 12:15 PM
Impact of Postoperative Chemoradiation for HPV Positive Oropharyngeal Cancers with Extranodal Extension and/or Positive Margins
Poster Presenter:
Presentation No : MO_29_2694
10:45 AM - 12:15 PM
Impact of Primary Payer on Survival in Patients <65 Years of Age with Localized Head and Neck Cancer Treated With Definitive Radiation Therapy
Poster Presenter:
Presentation No : MO_31_2732
10:45 AM - 12:15 PM
Impact of Surgery and External Beam Radiation Therapy on Local Control in the Treatment of Medullary Thyroid Carcinoma
Poster Presenter:
Presentation No : MO_40_2540
10:45 AM - 12:15 PM
Impact of Tumor Histology on Local Control in Patients with Primary Soft Tissue Sarcoma of the Extremity
Poster Presenter: – Memorial Sloan Kettering Cancer Center
Presentation No : MO_22_2876
10:45 AM - 12:15 PM
Improved Local Control with Internal Dose-Escalation for Melanoma Brain Metastases Treated with Stereotactic Radiosurgery
Poster Presenter:
Presentation No : MO_7_2640
10:45 AM - 12:15 PM
Improved Outcomes With Adjuvant Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiation Therapy for Resected Intracranial Metastases
Poster Presenter:
Presentation No : MO_6_2603
10:45 AM - 12:15 PM
Improved Overall and Cause-Specific Survival for Melanoma Brain metastasis Patients Treated with Stereotactic Radiosurgery and Immunotherapy
Poster Presenter:
Presentation No : MO_14_2820
10:45 AM - 12:15 PM
Incidence and Outcomes of HPV-associated Head and Neck Cancers in the United States: A Large Population-Based Analysis
Poster Presenter: – Brigham and Women's Hopsital
Presentation No : MO_27_2649
10:45 AM - 12:15 PM
Incidence, Pattern and Predictive Factors for Hypoglossal Nerve Palsy After Definitive Intensity-modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma (NPC)
Poster Presenter:
Presentation No : MO_23_2460
10:45 AM - 12:15 PM
Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma: An Updated Meta-Analysis and Meta-Regression of Randomized Trials.
Poster Presenter:
Presentation No : MO_35_2824
10:45 AM - 12:15 PM
Induction Chemotherapy Plus IMRT-Based Concurrent Chemoradiotherapy Versus Induction Chemotherapy Plus IMRT Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: A Retrospective Cohort Study
Poster Presenter:
Presentation No : MO_31_2726
10:45 AM - 12:15 PM
Induction Chemotherapy Using Gemcitabine and Cisplatin Followed by Hypofractionated Radiation Therapy in Locally Advanced Head and Neck Cancer
Poster Presenter:
Presentation No : MO_30_2706
10:45 AM - 12:15 PM
Induction chemotherapy with paclitaxel liposome, nedaplatin, and fluorouracil in patients with locally advanced nasopharyngeal carcinoma: a phase II study
Poster Presenter:
Presentation No : MO_37_2874
10:45 AM - 12:15 PM
Influence of PD-L1 Expression in Immune Cells on the Response to Radiation Therapy in Patients with Oropharyngeal Squamous Cell Carcinoma.
Poster Presenter:
Presentation No : MO_25_2594
10:45 AM - 12:15 PM
Initial clinical and advanced imaging outcomes from a multi-institutional phase I dose-escalation trial of RRx-001 plus whole brain radiation for patients with brain metastases
Poster Presenter:
Presentation No : MO_6_2621
10:45 AM - 12:15 PM
Initial Clinical Experience with Uni-Directional LDR Brachytherapy in the Treatment of Retroperitoneal Sarcoma
Poster Presenter:
Presentation No : MO_20_2599
10:45 AM - 12:15 PM
Initial Findings of Analysis of Circulating Tumor Cells in Patients with Brain Metastases of Breast Cancer
Poster Presenter:
Presentation No : MO_1_2486
10:45 AM - 12:15 PM
Initial Response Lag time in Flat versus Non-Flat beam frameless Image Guided Trigeminal Radiosurgery
Poster Presenter:
Presentation No : MO_14_2817
10:45 AM - 12:15 PM
Intensity-modulated proton therapy reduces acute treatment-related toxicities for patients with nasopharyngeal cancer: A case-control propensity score match study with volumetric modulated arc therapy
Poster Presenter:
Presentation No : MO_23_2554
10:45 AM - 12:15 PM
Intensity-modulated Proton Therapy with Dose Painting based on Hypoxia Imaging for Nasopharyngeal Cancer
Poster Presenter:
Presentation No : MO_38_2881
10:45 AM - 12:15 PM
Interim Safety and Toxicity Analysis of a Prospective Phase II Randomized Trial of Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation Therapy in Advanced Metastatic Disease
Poster Presenter: – University of California, San Diego
Presentation No : MO_34_2802
10:45 AM - 12:15 PM
Interplay of Age and Performance Status on Patterns of Care and Outcomes in Elderly Patients with Glioblastoma: A National Cancer Database Analysis
Poster Presenter:
Presentation No : MO_1_2472
10:45 AM - 12:15 PM
Investigating nationwide usage trends and relative efficacy of combined modality treatments for elderly glioblastoma patients
Poster Presenter:
Presentation No : MO_13_2804
10:45 AM - 12:15 PM
Investigating Semi-Quantitative in-Vivo Spatial and Dosimetric Analytical Algorithms to Report GBM Patterns of Failures Following Chemoradiation in the IMRT Era
Poster Presenter:
Presentation No : MO_13_2563
10:45 AM - 12:15 PM
Investigation of the Optimum S-1 Dosing Schedule of Concurrent Chemoradiotherapy for T2N0 Glottic Cancer: A Comparison of Alternate-Day Administration Versus Daily Administration
Poster Presenter:
Presentation No : MO_25_2598
10:45 AM - 12:15 PM
Investigation of the three-dimensional dose distribution of mandibular areas of origin of advanced osteoradionecrosis in oropharyngeal cancer patients receiving IMRT
Poster Presenter: – MD Anderson Cancer Center
Presentation No : MO_34_2785
10:45 AM - 12:15 PM
Involved site vs extended field radiation therapy for multiple myeloma of long bones after internal fixation
Poster Presenter:
Presentation No : MO_41_2461
10:45 AM - 12:15 PM
Is Malnutrition Associated with Postoperative Complications in Patients with Primary Bone Sarcomas?
Poster Presenter:
Presentation No : MO_20_2557
10:45 AM - 12:15 PM
Is Risk Group-Adapted Adjuvant Radiation Therapy Beneficial for WHO Grade I/II Skull Base Meningioma? a Propensity Score-Matched Analysis
Poster Presenter: – Yonsei University Health System
Presentation No : MO_14_2809
10:45 AM - 12:15 PM
Level IB Nodal Exclusion in Oropharyngeal Carcinomas Treated With Radiation Therapy: Safety, Efficacy, and a New Standard of Care in this Patient Population
Poster Presenter:
Presentation No : MO_30_2705
10:45 AM - 12:15 PM
Local failure and radionecrosis following single fraction stereotactic radiosurgery for surgical cavities from brain metastases
Poster Presenter:
Presentation No : MO_12_2787
10:45 AM - 12:15 PM
Local regional patterns of failure following postoperative IMRT for anaplastic thyroid cancer
Poster Presenter:
Presentation No : MO_40_2533
10:45 AM - 12:15 PM
Local Therapy in the Definitive Management of Castleman Disease
Poster Presenter:
Presentation No : MO_44_2539
10:45 AM - 12:15 PM
Local Tumor Control and Long-Term Overall Survival in 47 Patients With Anterior Skull Base Tumors Treated With Intraoperative Radiation Therapy
Poster Presenter:
Presentation No : MO_27_2646
10:45 AM - 12:15 PM
Locoregional Recurrence of De-escalated Radiation dose in Selected Nasopharyngeal carcinoma: Experience from a Single Center Institution
Poster Presenter:
Presentation No : MO_37_2860
10:45 AM - 12:15 PM
Loco-regional relapse and predictors of outcome in early stage oral cavity cancers (pT1-2N0) treated with surgical monotherapy with or without neck dissection: a multi-institutional study
Poster Presenter:
Presentation No : MO_32_2753
10:45 AM - 12:15 PM
Long term follow up of patients treated at a single institution using a passively scattered proton beam; observations around the occurrence of second malignancies.
Poster Presenter:
Presentation No : MO_19_2841
10:45 AM - 12:15 PM
Long term follow-up from a Phase I/II Trial Utilizing a Dose-Escalated Stereotactic Radiosurgery (SRS) Boost for Unfavorable Locally Advanced Oropharyngeal Cancer
Poster Presenter:
Presentation No : MO_37_2859
10:45 AM - 12:15 PM
Long term outcome of definitive chemo-IMRT for locally advanced nasopharyngeal cancer patients using Helical Tomotherapy.
Poster Presenter:
Presentation No : MO_26_2624
10:45 AM - 12:15 PM
Long Term Outcomes and Prognostic Factors of Head and Neck Soft Tissue Sarcoma (HNSTS) Treated with Definitive Therapy
Poster Presenter:
Presentation No : MO_20_2620
10:45 AM - 12:15 PM
Longitudinal Objective Speech and Swallow Function after Treatment with Definitive Radiation Therapy (RT) for Larynx Cancer in the Intensity Modulated Radiation Therapy (IMRT) Era
Poster Presenter:
Presentation No : MO_30_2704
10:45 AM - 12:15 PM
Long-term Outcomes and Imaging Response for Image-Guided Stereotactic Radiosurgery (IG-SRS) of Brain Arteriovenous Malformations (AVM)
Poster Presenter:
Presentation No : MO_15_2847
10:45 AM - 12:15 PM
Long-term outcomes for re-irradiation of recurrent head-and-neck cancers: Mature data from a large series.
Poster Presenter:
Presentation No : MO_26_2608
10:45 AM - 12:15 PM
Long-Term Outcomes of Adult Patients with High-Risk Acute Lymphoblastic Leukemia Undergoing Total Body Irradiation with or without Whole Brain Boost
Poster Presenter:
Presentation No : MO_42_2593
10:45 AM - 12:15 PM
Long-term prognostic effects of plasma EBV DNA load after induction chemotherapy in advanced nasopharyngeal carcinoma
Poster Presenter:
Presentation No : MO_28_2665
10:45 AM - 12:15 PM
Long-term Results of Radiation Therapy for Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphomas
Poster Presenter:
Presentation No : MO_42_2652
10:45 AM - 12:15 PM
Long-Term Survival and Late Complications of Intensity-Modulated Radiation Therapy for Recurrent Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_29_2686
10:45 AM - 12:15 PM
Long-Term Therapeutic Outcome and Prognostic Factors for Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: An Analysis of 608 Patients from Low-Endemic Regions of China
Poster Presenter:
Presentation No : MO_25_2600
10:45 AM - 12:15 PM
Low dose Bevacizumab in treatment of radiation necrosis post IGRT with Cyberknife boost with Temozolamide for Glioma patients
Poster Presenter:
Presentation No : MO_11_2738
10:45 AM - 12:15 PM
Low Grade, Indolent Lymphomas of the Head and Neck: Comparative Toxicity of Standard Versus Very Low Dose Radiation Therapy
Poster Presenter:
Presentation No : MO_41_2459
10:45 AM - 12:15 PM
Low-Dose (4 Gy) Radiation Therapy as an Effective Treatment Modality for Relapsed Refractory Mantle Cell Lymphoma
Poster Presenter: – MD Anderson Cancer Center
Presentation No : MO_43_2789
10:45 AM - 12:15 PM
Lymph node ratio as a predictor of distant metastases in major salivary gland carcinomas
Poster Presenter:
Presentation No : MO_27_2642
10:45 AM - 12:15 PM
Lymphopenia During Radiation Therapy In Patients With Oropharyngeal Cancer: Does It Affect Survival Outcomes?
Poster Presenter: – MD Anderson Cancer Center
Presentation No : MO_30_2723
10:45 AM - 12:15 PM
Machine learning can improve the accuracy and efficiency of output factor estimation for electron cutouts
Poster Presenter:
Presentation No : MO_18_2656
10:45 AM - 12:15 PM
Married Patients With Soft Tissue Sarcoma Have Improved Overall Survival Compared To Single Patients
Poster Presenter:
Presentation No : MO_20_2560
10:45 AM - 12:15 PM
Medulla Dose is Positively Associated with Sensation of Thirst & Midbrain Dose is Inversely Associated with Pain: Prospectively-Collected Patient-Reported Toxicities and Brainstem Dose in Head and Neck Cancer Radiation Therapy
Poster Presenter: – Winship Cancer Institute of Emory University
Presentation No : MO_23_2464
10:45 AM - 12:15 PM
Metalloproteinase inhibitor 4 to vascular endothelial growth factor A ratio is a prognostic factor of chemoradiation in glioblastoma
Poster Presenter:
Presentation No : MO_7_2896
10:45 AM - 12:15 PM
Metastasis directed therapy with definitive intent is associated with improved survival in metastatic head and neck cancer
Poster Presenter: – Memorial Sloan Kettering Cancer Center
Presentation No : MO_32_2758
10:45 AM - 12:15 PM
Microcystic Adnexal Carcinoma: Prognosis and Epidemiology Analysis of the Surveillance, Epidemiology, and End Results Database from 1973-2014
Poster Presenter:
Presentation No : MO_38_2499
10:45 AM - 12:15 PM
MMP2 and MMP3 Promote Laryngeal Squamous Cell Carcinoma Proliferation and Migration via Epithelial Mesenchymal Transformation
Poster Presenter:
Presentation No : MO_37_2867
10:45 AM - 12:15 PM
Modern Re-irradiation Versus Post-Bevacizumab Salvage Chemotherapy in Treating Recurrent High-Grade Gliomas
Poster Presenter:
Presentation No : MO_11_2741
10:45 AM - 12:15 PM
Monte-Carlo Based Total-Body Irradiation Using Linac-Based Volumetric Modulated Arc Therapy
Poster Presenter:
Presentation No : MO_43_2825
10:45 AM - 12:15 PM
National Practice Patterns of Proton versus Photon Therapy in the Treatment of Adult Patients with Primary Brain Tumors
Poster Presenter:
Presentation No : MO_3_2515
10:45 AM - 12:15 PM
Nationwide Characteristics of Providers Utilizing Tumor Treating Fields for Newly Diagnosed Glioblastoma
Poster Presenter:
Presentation No : MO_10_2709
10:45 AM - 12:15 PM
Neoadjuvant Chemotherapy (NAC) Associated With Improved Survival in High Risk Nasopharyngeal Carcinoma (NPC) Patients Treated With Definitive Concurrent Chemoradiation Therapy (CCRT)
Poster Presenter:
Presentation No : MO_26_2615
10:45 AM - 12:15 PM
Neuroanatomical differences in the brains of cerebral metastasized breast cancer patients:meningeal carcinomatosa patients vs. brain oligometastatic patients vs. multiple metastastic brain patients
Poster Presenter:
Presentation No : MO_4_2559
10:45 AM - 12:15 PM
Neurological death is common in patients with EGFR mutant non-small cell lung cancer
Poster Presenter:
Presentation No : MO_8_2677
10:45 AM - 12:15 PM
Neutron Radiation Therapy and Gamma Knife Radiosurgery Boost for Locally Advanced Adenoid Cystic Carcinoma With Skull Base Invasion
Poster Presenter:
Presentation No : MO_32_2759
10:45 AM - 12:15 PM
Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability
Poster Presenter:
Presentation No : MO_15_2848
10:45 AM - 12:15 PM
Ocular Brachytherapy for Intra-ocular Melanoma: Experience and Outcomes in The Province of Alberta
Poster Presenter:
Presentation No : MO_2_2502
10:45 AM - 12:15 PM
Oligodendroglioma Patients with 1p/19q Co-deletion Treated with Early or Delayed Radiation Therapy over the Last Two Decades: A Multi-institutional Report
Poster Presenter:
Presentation No : MO_8_2662
10:45 AM - 12:15 PM
Outcome analysis and impact of prognostic factors on survival of 111 Adult Medulloblastoma patients : A long term single institutional study.
Poster Presenter:
Presentation No : MO_8_2675
10:45 AM - 12:15 PM
Outcome and Role of Radiation Therapy in Stage I-II Mesenteric Diffuse Large B-Cell Lymphoma
Poster Presenter: – Princess Margaret Cancer Centre
Presentation No : MO_43_2821
10:45 AM - 12:15 PM
Outcome and Toxicity of Hypofractionated Conformal Radiation Therapy(HCRT) in Early Glottis Cancer, a Baseline for Comparison in the IMRT Era
Poster Presenter:
Presentation No : MO_23_2561
10:45 AM - 12:15 PM
Outcome Following Radiation Therapy for Locally Advanced Cutaneous Head and Neck Squamous Cell Carcinoma and Analysis of Factors Associated with Recurrence
Poster Presenter:
Presentation No : MO_34_2788
10:45 AM - 12:15 PM
Outcomes after Salvage Therapy in Oral Cavity Squamous Cell Carcinoma (OCSCC) Patients Who Developed Locoregional Failure (LRF) after Definitive Surgery and Adjuvant (chemo)Radiotherapy: A Multi-Institutional Collaborative Study
Poster Presenter: – Memorial Sloan Kettering Cancer Center
Presentation No : MO_35_2835
10:45 AM - 12:15 PM
Outcomes and Practice Patterns for Aggressive Local Therapy in Newly Diagnosed Stage IV Soft Tissue Sarcoma: An NCDB Analysis
Poster Presenter:
Presentation No : MO_22_2536
10:45 AM - 12:15 PM
Outcomes and Prognostic Factors for Major Salivary Gland Carcinoma Treated with Surgery and Postoperative Radiation Therapy
Poster Presenter:
Presentation No : MO_34_2803
10:45 AM - 12:15 PM
Outcomes and Prognostic Factors of Locally Recurrent Nasopharyngeal Carcinoma Receiving Salvage Re-irradiation in the IMRT Era
Poster Presenter:
Presentation No : MO_23_2457
10:45 AM - 12:15 PM
Outcomes Following Definitive Single Fraction Stereotactic Radiosurgery for Larger Brain Metastases
Poster Presenter:
Presentation No : MO_9_2690
10:45 AM - 12:15 PM
Outcomes Following Radiation for Cutaneous Squamous Cell Carcinoma (cSCC)
Poster Presenter:
Presentation No : MO_25_2604
10:45 AM - 12:15 PM
Outcomes following Stereotactic Radiation (SRS/SRT) plus Surgery versus SRS/SRT Alone for Single or Solitary Metastasis in Patients with Controlled Systemic Disease: A Single-Institution Study
Poster Presenter:
Presentation No : MO_12_2764
10:45 AM - 12:15 PM
Outcomes for advanced melanoma with brain metastases treated with stereotactic radiosurgery (SRS) with and without anti-PD1/PDL1 therapy
Poster Presenter:
Presentation No : MO_6_2597
10:45 AM - 12:15 PM
Outcomes for oropharyngeal squamous cell carcinoma (OPSCC) following transoral robotic surgery (TORS)
Poster Presenter:
Presentation No : MO_23_2550
10:45 AM - 12:15 PM
Outcomes in BRAFV600e-mutant melanoma brain metastases managed with radiosurgery: a multi-institutional assessment of craniotomy mitigation
Poster Presenter:
Presentation No : MO_2_2498
10:45 AM - 12:15 PM
Outcomes of Curative (Chemo)Radiotherapy for Patients Who Are Borderline for Curative Management of Squamous Cell Carcinoma of Head and Neck
Poster Presenter:
Presentation No : MO_37_2872
10:45 AM - 12:15 PM
Outcomes of Intensity Modulated Irradiation for Sinonasal Cancers in the Modern Era
Poster Presenter:
Presentation No : MO_31_2475
10:45 AM - 12:15 PM
Outcomes of Patients With Connective Tissue Diseases Receiving Radical Radiation Therapy for Nasopharyngeal Carcinoma in the IMRT Era - A Matched Cohort Analysis
Poster Presenter:
Presentation No : MO_25_2590
10:45 AM - 12:15 PM
Outcomes of Proton and Carbon Ion Radiation Therapy for Head and Neck Sarcomas
Poster Presenter:
Presentation No : MO_37_2873
10:45 AM - 12:15 PM
Outcomes of uveal melanoma with distant metastasis at initial staging: Impact of primary tumor therapy
Poster Presenter:
Presentation No : MO_10_2717
10:45 AM - 12:15 PM
Outcomes of whole brain radiation with simultaneous in-field boost (SIB) for the treatment of brain metastases
Poster Presenter:
Presentation No : MO_16_2890
10:45 AM - 12:15 PM
Palliative Radiation Therapy for Vertebral Metastases and Metastatic Cord Compression in Patients Treated with anti-PD-1 Therapy
Poster Presenter:
Presentation No : MO_3_2509
10:45 AM - 12:15 PM
Patient Factors Predicting Intracranial Progression: Optimizing MRI Surveillance Interval Following Brain Metastases SRS
Poster Presenter:
Presentation No : MO_10_2721
10:45 AM - 12:15 PM
Patient-Reported Outcome Measures of Long-Term Swallowing Function after Oropharyngeal Radiation Therapy: A Cross-Sectional Methods Comparison
Poster Presenter:
Presentation No : MO_39_2519
10:45 AM - 12:15 PM
Patterns of Care Among Elderly US Veterans treated for Head and Neck Cancer with Radiation Therapy
Poster Presenter:
Presentation No : MO_35_2840
10:45 AM - 12:15 PM
Patterns of Care and Outcomes in Patients with Squamous Cell Carcinoma of the Buccal Mucosa
Poster Presenter:
Presentation No : MO_39_2518
10:45 AM - 12:15 PM
Patterns of care and outcomes of neoadjuvant chemotherapy in locally advanced HPV positive oropharyngeal carcinoma: A National Cancer Database Analysis
Poster Presenter:
Presentation No : MO_36_2843
10:45 AM - 12:15 PM
Patterns of Failure After Postoperative Intensity-Modulated Radiation Therapy for Locally Advanced Buccal Cancer: Initial Masticator Space Involvement Is the Key Factor of Recurrence
Poster Presenter: – Chi Mei Medical Center
Presentation No : MO_31_2743
10:45 AM - 12:15 PM
Patterns of Failure and Clinical Outcomes of Post-operative Buccal Mucosa Cancers Treated With Ipsilateral Radiation Therapy
Poster Presenter:
Presentation No : MO_28_2678
10:45 AM - 12:15 PM
Patterns of Local Extension and Nodal Involvement From 1300 Nasopharyngeal Carcinoma Patients Based on Magnetic Resonance Imaging
Poster Presenter:
Presentation No : MO_39_2508
10:45 AM - 12:15 PM
Patterns of Local Failures and Suggestions for Reduction of Clinical Target Volume for NasopharyngealCarcinoma Patients Without Cervical Lymph Node Metastasis
Poster Presenter:
Presentation No : MO_31_2742
10:45 AM - 12:15 PM
Patterns of Local or Regional Recurrence after Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_27_2639
10:45 AM - 12:15 PM
Patterns of Relapse After Salvage Autologous Hematopoietic Cell Transplantation for Hodgkin's Lymphoma: Should Sites of Relapse Relative to Initially Involved Sites Be Used to Guide Indications for Peritransplant Radiation Therapy
Poster Presenter:
Presentation No : MO_41_2567
10:45 AM - 12:15 PM
Peri-Stem Cell Transplant Toxicity after Craniospinal Irradiation: The Influence of Timing
Poster Presenter:
Presentation No : MO_41_2570
10:45 AM - 12:15 PM
Permanent Interstitial Brachytherapy (PIB) using Cesium-131 in Vaginal Melanoma - A New Wide-Local Radiation Technique
Poster Presenter:
Presentation No : MO_21_2658
10:45 AM - 12:15 PM
Persistently Elevated Soluble MHC Class I Polypeptide-Related Sequence a and Transforming Growth Factor-1 Levels Are Poor Prognostic Factors in Head and Neck Squamous Cell Carcinoma after Definitive Chemoradiotherapy
Poster Presenter:
Presentation No : MO_36_2489
10:45 AM - 12:15 PM
Phase II Prospective Trial to Assess the Feasibility and Efficacy of Dynamic 24Gy Single Dose Ablative Stereotactic Radiation Therapy in Oligometastatic Human Cancer
Poster Presenter:
Presentation No : MO_3_2520
10:45 AM - 12:15 PM
Pituitary dysfunction in patients after IMRT for nasopharyngeal carcinoma
Poster Presenter:
Presentation No : MO_38_2887
10:45 AM - 12:15 PM
Pneumonitis Rates With and Without Lung Blocking Following a 12 Gy BID Low Dose-Rate Co-60 Total Body Irradiation Regimen
Poster Presenter:
Presentation No : MO_43_2750
10:45 AM - 12:15 PM
Point-of-care local failure and overall survival prediction models for meningioma
Poster Presenter:
Presentation No : MO_10_2718
10:45 AM - 12:15 PM
Post-operative cavity radiation therapy with standard fractionation for brain metastases
Poster Presenter:
Presentation No : MO_1_2483
10:45 AM - 12:15 PM
Post-Radiation Immunosuppression is Associated with Poor Clinical Outcomes in HPV-negative Oropharyngeal Cancers
Poster Presenter:
Presentation No : MO_30_2700
10:45 AM - 12:15 PM
Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who receive upfront SRS Alone
Poster Presenter:
Presentation No : MO_9_2683
10:45 AM - 12:15 PM
Practice Patterns in Human Papilloma Virus-Associated Oropharyngeal Cancer and Strategies for Deintensification of Therapy: A Nationwide Survey of Radiation Oncologists
Poster Presenter: – University of Maryland School of Medicine, Baltimore
Presentation No : MO_31_2733
10:45 AM - 12:15 PM
Pre- and postoperative prediction of long-term meningioma outcomes
Poster Presenter:
Presentation No : MO_17_2465
10:45 AM - 12:15 PM
Pre- vs post-operative radiation therapy, and time to surgery: An exploratory analysis of predictors of survival in soft tissue sarcoma stratified by histological subtype
Poster Presenter:
Presentation No : MO_21_2482
10:45 AM - 12:15 PM
PRE.M.I.S.E. (PREdiction Models in Stereotactic External Radiation Therapy). Could the Creation of an Ontology Pave the Way for a Prediction Model for Stereotactic Radiation Therapy?
Poster Presenter:
Presentation No : MO_18_2701
10:45 AM - 12:15 PM
Predicting PD-L1 Expression using Radiomics in Oropharyngeal Cancer Patients treated with Definitive Radiation
Poster Presenter:
Presentation No : MO_34_2810
10:45 AM - 12:15 PM
Predictors for and Clinical Impact of Time between Surgical Resection and Radiation Therapy in Glioblastoma: Analysis of the National Cancer Database
Poster Presenter:
Presentation No : MO_6_2609
10:45 AM - 12:15 PM
Predictors of contralateral and bilateral lymph node metastases in head and neck cancer: A closer look at the ipsilateral neck
Poster Presenter:
Presentation No : MO_26_2617
10:45 AM - 12:15 PM
Predictors of Distant Failure in Locally Advanced p16-positive Oropharyngeal Squamous Cell Carcinoma
Poster Presenter: – Southern California Permanente Medical Group
Presentation No : MO_25_2606
10:45 AM - 12:15 PM
Predictors of Lymph Node Involvement by Soft Tissue Sarcoma: an Analysis of the National Cancer Database (NCDB)
Poster Presenter:
Presentation No : MO_22_2784
10:45 AM - 12:15 PM
Preliminary Study of Cell Survival Modelling Considering Stochastic Fluctuations in Cell Survival Rates During Radiation Therapy
Poster Presenter:
Presentation No : MO_19_2791
10:45 AM - 12:15 PM
Preoperative Hypofractionated Radiation Therapy in Soft Tissue Sarcoma of the Extremity: Outcomes from the National Cancer Database.
Poster Presenter:
Presentation No : MO_22_2755
10:45 AM - 12:15 PM
Pretreatment FDG PET-based metabolic nodal sub-tumor volumes improve node-specific failure-free survival prediction in low-risk oropharyngeal cancer patients following chemoradiation therapy
Poster Presenter: – University of Michigan
Presentation No : MO_35_2822
10:45 AM - 12:15 PM
Pretreatment Texture Analysis of Routine Magnetic Resonance Images and Shape Analysis of the Diffusion Tensor predict Volumetric Response after Radiosurgery for Meningiomas
Poster Presenter:
Presentation No : MO_11_2691
10:45 AM - 12:15 PM
Primary Gastric Diffuse Large B-Cell Lymphoma treated with Abbreviated Chemoimmunotherapy and Contemporary Radiation Therapy has Excellent Outcomes with Minimal Toxicity
Poster Presenter:
Presentation No : MO_41_2462
10:45 AM - 12:15 PM
Prognostic and functional characterization of AQP1 and AQP4 in patients with glioma based on TCGA database
Poster Presenter:
Presentation No : MO_3_2490
10:45 AM - 12:15 PM
Prognostic Factors in Adult Localized Chemotherapy-Sensitive Soft Tissue Sarcoma
Poster Presenter: – University of Utah Huntsman Cancer Institute
Presentation No : MO_21_2470
10:45 AM - 12:15 PM
Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiation Therapy
Poster Presenter:
Presentation No : MO_28_2661
10:45 AM - 12:15 PM
Prognostic Role of PD-1/PD-L1 Expression in Patients With Head And Neck Cancer and Its Correlation With HPV/p16
Poster Presenter:
Presentation No : MO_34_2780
10:45 AM - 12:15 PM
Prognostic Significance of Immune Microenvironmental Factors in Undifferentiated Nasopharyngeal Carcinoma Patients Treated With Chemoradiotherapy
Poster Presenter:
Presentation No : MO_24_2566
10:45 AM - 12:15 PM
Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-modulated Radiation Therapy
Poster Presenter:
Presentation No : MO_32_2484
10:45 AM - 12:15 PM
Prognostic value of upfront non-surgical management and/or surgical margin status for advanced sinonasal malignancies
Poster Presenter: – University of California, San Francisco
Presentation No : MO_38_2883
10:45 AM - 12:15 PM
Propensity-Matched Analysis of Prognosis Following Whole Brain Radiation Therapy Alone Versus Whole Brain Radiation Therapy Combined with Local Boost in Small Cell Lung Cancer Patients With Brain Metastases
Poster Presenter:
Presentation No : MO_16_2894
10:45 AM - 12:15 PM
Prophylactic Gabapentin Combined with Methadone Improves Overall Health in Patients Undergoing Chemoradiation for Head and Neck Cancer While Reducing Use of Opioids with High Abuse Potential: Early Results of a Prospective Randomized Trial
Poster Presenter:
Presentation No : MO_24_2468
10:45 AM - 12:15 PM
Prospective Phase II Study of Scanned Beam Proton Therapy for Spine Sarcomas
Poster Presenter:
Presentation No : MO_22_2762
10:45 AM - 12:15 PM
Prostate Lesion Malignancy Classification from Multiparametric MRI Images Using Convolution Neural Network
Poster Presenter:
Presentation No : MO_19_2870
10:45 AM - 12:15 PM
Proton beam re-irradiation as salvage therapy for recurrent intracranial meningiomas
Poster Presenter:
Presentation No : MO_5_2583
10:45 AM - 12:15 PM
Quality of Life, Survival, and Recurrence Patterns following Adjuvant Stereotactic Radiosurgery for Resected Brain Metastases
Poster Presenter:
Presentation No : MO_1_2455
10:45 AM - 12:15 PM
Quantitative Analysis of Weight of Prognostic Factors Related to Radiation Pneumonitis using Statistical Analysis and Artificial Neural Network
Poster Presenter:
Presentation No : MO_17_2627
10:45 AM - 12:15 PM
Quantitative MR measurements of mean diffusivity in glioblastoma patients with Tumor Treating Fields plus standard therapy versus standard treatment alone
Poster Presenter:
Presentation No : MO_15_2857
10:45 AM - 12:15 PM
Radiation Dose Escalation for Localized Ependymoma
Poster Presenter: – University of Pennsylvania
Presentation No : MO_15_2852
10:45 AM - 12:15 PM
Radiation Dose-Volume Tolerance for Hypofractionated Head-and-Neck Retreatments: A Report from the HyTEC Normal Tissue Complication Probability Working Group for Carotid Blowout Syndrome
Poster Presenter: – West Virginia University School of Medicine
Presentation No : MO_36_2855
10:45 AM - 12:15 PM
Radiation effects in patients with CD19 and CD30 targeted agents
Poster Presenter:
Presentation No : MO_42_2713
10:45 AM - 12:15 PM
Radiation fractionation regimen selection for palliation of metastatic multiple myeloma in the era of biological therapeutics
Poster Presenter:
Presentation No : MO_44_2829
10:45 AM - 12:15 PM
Radiation Therapy Demonstrates Persistent Overall Survival Benefit in Locally Advanced or Metastatic Anaplastic Thyroid Cancer
Poster Presenter: – Albert Einstein College of Medicine
Presentation No : MO_28_2669
10:45 AM - 12:15 PM
Radiation Therapy for Adult Soft Tissue Sarcomas of the Head and Neck
Poster Presenter:
Presentation No : MO_30_2724
10:45 AM - 12:15 PM
Radiation therapy for salivary gland MALT lymphoma: Ultra low dose treatment spares salivary function and achieves excellent outcomes
Poster Presenter:
Presentation No : MO_41_2571
10:45 AM - 12:15 PM
Radiation Therapy for True Vocal Cord Carcinoma in Situ: A 55 Year Single-Institution Experience
Poster Presenter:
Presentation No : MO_29_2688
10:45 AM - 12:15 PM
Radiation Therapy in Extracranial Chondrosarcomas: A Multicenter French Sarcoma Group and Rare Cancer Network Study
Poster Presenter:
Presentation No : MO_22_2862
10:45 AM - 12:15 PM
Radiation Therapy in Intrathoracic Sarcomas. A Rare Cancer Network Study
Poster Presenter:
Presentation No : MO_21_2692
10:45 AM - 12:15 PM
Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience over 4 Decades
Poster Presenter:
Presentation No : MO_20_2636
10:45 AM - 12:15 PM
Radiation Treatment outcome with Reduce clinical target volume (CTV) in patients with oropharynx cancer
Poster Presenter:
Presentation No : MO_36_2856
10:45 AM - 12:15 PM
Radiation-induced edema after single or multi-fraction stereotactic radiosurgery (SRS) for non-base of skull (non-BOS) meningioma: A pooled analysis
Poster Presenter:
Presentation No : MO_10_2714
10:45 AM - 12:15 PM
Radiation-induced vascular malformations mimicking tumor in MRI-based treatment response assessment maps (TRAMs)
Poster Presenter:
Presentation No : MO_11_2745
10:45 AM - 12:15 PM
Radiation-induced White Matter Injury Following Radiation Therapy in Glioblastoma patients
Poster Presenter:
Presentation No : MO_13_2506
10:45 AM - 12:15 PM
Radiomics Analysis Using Contrast-Enhanced CT: Predict Treatment Response to Pulsed Low Dose Rate Radiation Therapy in Gastric Carcinoma with Peritoneal Cavity Metastasis
Poster Presenter:
Presentation No : MO_17_2469
10:45 AM - 12:15 PM
Radiomics Prediction of Radiation Treatment Outcomes in Oropharyngeal Cancer: A Clinical and Image Repository in Concert with the Cancer Imaging Archive (TCIA)
Poster Presenter:
Presentation No : MO_24_2505
10:45 AM - 12:15 PM
Radiosurgery and Checkpoint Blockade Confer Pathologic Complete Response in Mouse Glioblastoma Multiforme with Distinct Immunologic and Radiographic Signatures
Poster Presenter:
Presentation No : MO_2_2496
10:45 AM - 12:15 PM
Radiosurgery outcome related to chemotherapy association in relapsed glioblastoma multiforme.
Poster Presenter:
Presentation No : MO_12_2766
10:45 AM - 12:15 PM
Randomized Double-blind, Placebo-Controlled Phase III trial Evaluating the Effect of Oral glutamine on Radiation-induced Oral Mucositis and Neck Dermatitis in Head and Neck Cancer Patients
Poster Presenter:
Presentation No : MO_29_2697
10:45 AM - 12:15 PM
Rapid In-Field Failures Following Adjuvant Radiation for Buccal Squamous Cell Carcinoma
Poster Presenter:
Presentation No : MO_39_2507
10:45 AM - 12:15 PM
Real-world plaque brachytherapy clinical practices among Ocular Oncology Study Consortium treatment centers
Poster Presenter:
Presentation No : MO_25_2586
10:45 AM - 12:15 PM
Reirradiation of Recurrent High Grade Gliomas: Outcomes and Prognostic Factors
Poster Presenter:
Presentation No : MO_1_2488
10:45 AM - 12:15 PM
Relationship between Expression of ERCC1 and Effect of Cisplatin Concurrent Chemoradiation in Stage II-III Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_36_2491
10:45 AM - 12:15 PM
Report of Neurotoxicity after Concurrent Whole Brain Radiation Therapy and Checkpoint Blockade Immunotherapy for Patients with Brain Metastases
Poster Presenter:
Presentation No : MO_13_2794
10:45 AM - 12:15 PM
Response Rates of Nodal Versus Extranodal Follicular and Marginal Zone Lymphomas to Very Low Dose Radiation Therapy of Only 4 Gy
Poster Presenter:
Presentation No : MO_41_2551
10:45 AM - 12:15 PM
Response to local treatment modalities in patients with primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma
Poster Presenter: – Moffitt Cancer Center
Presentation No : MO_44_2886
10:45 AM - 12:15 PM
Results of Hypofractionated Stereotactic Radiation Therapy (HSRT) for Large Brain Metastases and Resection Cavities
Poster Presenter:
Presentation No : MO_7_2635
10:45 AM - 12:15 PM
Risk Factors for Early Cognitive Deterioration after Whole-Brain Radiation Therapy for Brain Metastasis
Poster Presenter:
Presentation No : MO_10_2722
10:45 AM - 12:15 PM
Risk of visual toxicity following fractionated proton vs photon radiation therapy for patients with meningiomas
Poster Presenter:
Presentation No : MO_1_2478
10:45 AM - 12:15 PM
Risk-Adapted Survival Benefit of Intensity-Modulated Radiation Therapy in Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: A Multicenter Study
Poster Presenter: – Cancer Institute & Hospital Chinese Acedemy of Medical Sciences
Presentation No : MO_44_2837
10:45 AM - 12:15 PM
Risk-Based Optimization of Intensity-Modulated Radiation Therapy Guideline for Post-Operative Oral Cavity Cancer
Poster Presenter:
Presentation No : MO_23_2556
10:45 AM - 12:15 PM
Risk-Index of Colorectal Cancer to Triage for Screening
Poster Presenter:
Presentation No : MO_18_2748
10:45 AM - 12:15 PM
Role of Hypofractionated Radiation Therapy in a Multidisiplinary Approach to Treat Persistent Cushing's Disease
Poster Presenter:
Presentation No : MO_12_2781
10:45 AM - 12:15 PM
Role of radiation therapy in high-grade, small soft tissue sarcomas
Poster Presenter:
Presentation No : MO_22_2510
10:45 AM - 12:15 PM
Safety and clinical outcomes of ipilimumab and nivolumab plus concurrent stereotactic radiosurgery for brain metastases
Poster Presenter:
Presentation No : MO_4_2535
10:45 AM - 12:15 PM
Safety and Efficacy of Proton Beam Therapy for High-Grade Glioma: Initial Report From the Proton Collaborative Group(PCG)
Poster Presenter:
Presentation No : MO_15_2846
10:45 AM - 12:15 PM
Safety of TTFields applied to the torso: Meta-analysis of 176 patients from four phase I-II trials
Poster Presenter:
Presentation No : MO_16_2864
10:45 AM - 12:15 PM
Safety of Tumor Treating Fields and Concomitant Radiation Therapy for Newly Diagnosed Glioblastoma in a Pilot Study
Poster Presenter:
Presentation No : MO_3_2522
10:45 AM - 12:15 PM
Safety profile of tumor treating fields in adult glioblastoma patients with implanted non-programmable shunts, programmable shunts, and pacemakers/defibrillators: 6-year updated retrospective analysis
Poster Presenter:
Presentation No : MO_7_2630
10:45 AM - 12:15 PM
Safety, efficacy, and setup accuracy of patients undergoing multi-level spine stereotactic radiosurgery
Poster Presenter: – University of Michigan
Presentation No : MO_4_2541
10:45 AM - 12:15 PM
SBRT for spine lesions: A novel optimized delivery technique
Poster Presenter:
Presentation No : MO_14_2823
10:45 AM - 12:15 PM
Scar Bolus Omission During Adjuvant Intensity Modulated Radiation Therapy (IMRT) Does Not Increase Risk of Incisional Recurrence for Oral Cavity Cancers
Poster Presenter:
Presentation No : MO_27_2467
10:45 AM - 12:15 PM
Severe lymphopenia after chemoradiation treatment is associated with worse survival in patients with newly diagnosed GBM
Poster Presenter:
Presentation No : MO_13_2806
10:45 AM - 12:15 PM
Should Depth of Invasion Determine the Need for Postoperative Radiation Therapy in Early-Stage Oral Tongue Cancer
Poster Presenter:
Presentation No : MO_26_2632
10:45 AM - 12:15 PM
Siglec-8 Inhibits Malignancies via Mitochondria-dependent Apoptosis Pathway in Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_29_2693
10:45 AM - 12:15 PM
Similar local control rates for patients with meningiomas treated with proton therapy vs. IMRT
Poster Presenter:
Presentation No : MO_15_2839
10:45 AM - 12:15 PM
Simulation Order for Patients Undergoing Robotic-based SBRT: Identifying Predictors of Lengthier Insurance Authorization
Poster Presenter: – NYU Winthrop Hospital
Presentation No : MO_18_2479
10:45 AM - 12:15 PM
Single Fraction and Fractionated Radiosurgery for Treatment of Brainstem Metastases
Poster Presenter:
Presentation No : MO_14_2812
10:45 AM - 12:15 PM
Single Fraction Spine Stereotactic Radiosurgery for Epidural Tumors
Poster Presenter:
Presentation No : MO_5_2564
10:45 AM - 12:15 PM
Single-Isocenter, Volumetric Modulated Arc Radiosurgery for Multiple Brain Metastases in a Single Session
Poster Presenter:
Presentation No : MO_6_2623
10:45 AM - 12:15 PM
Software and Automation Algorithms for Chart Rounds: Improving the Peer-to-Peer Review Process.
Poster Presenter:
Presentation No : MO_18_2682
10:45 AM - 12:15 PM
Sparing of the Cardiac Valves and Left Ventricle using Proton Therapy with ECG-gated CT with Coronary Angiography for the Treatment of Mediastinal Lymphoma
Poster Presenter:
Presentation No : MO_42_2648
10:45 AM - 12:15 PM
Spine Stereotactic Body Radiation Therapy with Concurrent Systemic Therapies for Treatment of Metastatic Breast Cancer
Poster Presenter:
Presentation No : MO_16_2895
10:45 AM - 12:15 PM
Spine stereotactic radiosurgery in the treatment of metastatic pheochromocytoma: an updated case series
Poster Presenter:
Presentation No : MO_11_2746
10:45 AM - 12:15 PM
Spine stereotactic radiosurgery offers excellent local control in patients with bulky spinal disease
Poster Presenter:
Presentation No : MO_7_2625
10:45 AM - 12:15 PM
Squamous cell carcinoma of unknown primary of the head and neck - A hospital based analysis of outcomes
Poster Presenter:
Presentation No : MO_23_2555
10:45 AM - 12:15 PM
Stereotactic Body Radiation Therapy (SBRT) for Spinal Metastases at the Extremes of the Spine: Imaging-Based Outcomes for Cervical and Sacral Metastases
Poster Presenter:
Presentation No : MO_16_2868
10:45 AM - 12:15 PM
Stereotactic Body Radiation Therapy is an Effective and Safe Treatment for Benign Spinal Tumors
Poster Presenter:
Presentation No : MO_12_2778
10:45 AM - 12:15 PM
Stereotactic intracranial ablative radiation therapy for brain metastases with a mono-isocenter no-coplanar dedicated system: A preliminary dosimetric and clinical report
Poster Presenter: – Sacro Cuore Don Calabria CANCER CARE CENTER
Presentation No : MO_1_2473
10:45 AM - 12:15 PM
Stereotactic Radiosurgery (SRS) for Vestibular Schwannoma: Longitudinal Audiologic Assessment in Single and Fractionated Treatments.
Poster Presenter:
Presentation No : MO_7_2637
10:45 AM - 12:15 PM
Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing
Poster Presenter:
Presentation No : MO_14_2807
10:45 AM - 12:15 PM
Stereotactic Radiosurgery as a Component of Treatment for Brain Metastases in Small Cell Lung Cancer Patients
Poster Presenter:
Presentation No : MO_16_2884
10:45 AM - 12:15 PM
Stereotactic Radiosurgery for Brain Metastases of Small Cell Lung Cancer at Diagnosis: Local Management Patterns
Poster Presenter:
Presentation No : MO_4_2534
10:45 AM - 12:15 PM
Stereotactic radiosurgery for hemorrhagic brain metastases from malignant melanoma
Poster Presenter:
Presentation No : MO_5_2589
10:45 AM - 12:15 PM
Stereotactic Radiosurgery for Vestibular Schwannoma: Longitudinal Radiographic Outcomes Single and Fractionated Treatments.
Poster Presenter:
Presentation No : MO_7_2641
10:45 AM - 12:15 PM
Stereotactic Radiosurgery with Concurrent HER2-directed Therapy is Associated with Improved Objective Response for Breast Cancer Brain Metastasis
Poster Presenter: – Case Western Reserve University School of Medicine
Presentation No : MO_7_2631
10:45 AM - 12:15 PM
Stress Induced Overexpression of Stanniocalcin 2 (STC2) Plays Key Role in Radiation Resistance and Metastasis of Nasopharyngeal Carcinomas
Poster Presenter:
Presentation No : MO_33_2775
10:45 AM - 12:15 PM
Study on Optimal Plan Approach for Dual Arcs Volumetric Modulated Arc Therapy for Oropharyngeal Cancer
Poster Presenter:
Presentation No : MO_33_2769
10:45 AM - 12:15 PM
Suboptimal Outcomes in Patients with Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases Treated with Surgery and Radiation Therapy
Poster Presenter:
Presentation No : MO_36_2849
10:45 AM - 12:15 PM
Substantial Heterogeneity Amongst Radiation Oncologists in Adjuvant Therapy Recommendations for Patients Post-Transoral Robotic Surgery: A Patterns of Care Survey
Poster Presenter: – University of Maryland School of Medicine, Baltimore
Presentation No : MO_29_2685
10:45 AM - 12:15 PM
Subventricular Zone (SVZ) Radiation Dose and Outcomes in Patients with Glioblastoma Multiforme (GBM)
Poster Presenter:
Presentation No : MO_1_2458
10:45 AM - 12:15 PM
Survival Advantage to Combined Modality Therapy Seen in Multiple Subgroups Within Anaplastic Thyroid Carcinoma: A Propensity-Score Matched Analysis of the National Cancer Data Base
Poster Presenter:
Presentation No : MO_35_2833
10:45 AM - 12:15 PM
Survival and Prognostic Factors in Patients with Gastrointestinal Cancers and Brain Metastases
Poster Presenter:
Presentation No : MO_9_2736
10:45 AM - 12:15 PM
Survival Effect Difference of Whole-Brain Radiation Therapy and TKIs in Patients with Brain Metastases from Non-Small Cell Lung Cancer Stratified by EGFR Mutation Status
Poster Presenter:
Presentation No : MO_9_2698
10:45 AM - 12:15 PM
Survival Following Definitive Surgery or Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Larynx: An Analysis of the National Cancer Database
Poster Presenter:
Presentation No : MO_32_2477
10:45 AM - 12:15 PM
Systems Radiopharmacotherapy- A Paradigm in Drug Repurposing with Immune Modulatory Potential.
Poster Presenter:
Presentation No : MO_19_2815
10:45 AM - 12:15 PM
TCP and Dose Response after Brachytherapy for Choroidal Melanoma
Poster Presenter:
Presentation No : MO_25_2592
10:45 AM - 12:15 PM
Temporal Lobe Radiation Necrosis After Primary Radiation involving the Skull Base with Proton Therapy
Poster Presenter:
Presentation No : MO_32_2752
10:45 AM - 12:15 PM
Temporal Lobe Radiation Necrosis After Proton Re-irradiation Therapy Involving the Skull Base
Poster Presenter:
Presentation No : MO_29_2695
10:45 AM - 12:15 PM
Temporalis Muscle Width as a Measure of Sarcopenia Independently Predicts Overall Survival in Patients with Newly Diagnosed Glioblastoma
Poster Presenter:
Presentation No : MO_3_2527
10:45 AM - 12:15 PM
The Association Between Facility Characteristics and Survival in Patients with Merkel Cell Carcinoma
Poster Presenter:
Presentation No : MO_43_2882
10:45 AM - 12:15 PM
The Association of Canonical Speech- and Swallow-Related Dosimetric Constraints with Patient-Reported Quality of Life Outcomes: Results from a Phase II Trial of Dose De-Escalated Chemoradiation for HPV-Associated, Locally-Advanced Oropharyngeal Carcinoma
Poster Presenter: – University of California, Los Angeles
Presentation No : MO_27_2574
10:45 AM - 12:15 PM
The Clinical Results of Radiation Therapy for Spinal Cord Ependymoma with Adverse Prognostic Features: A Single-Institution Experience
Poster Presenter:
Presentation No : MO_4_2545
10:45 AM - 12:15 PM
The Development of a Prediction Model using Deep Learning for Short Term Prognosis in Patients Seen in a Palliative Rapid Access Clinic
Poster Presenter:
Presentation No : MO_17_2610
10:45 AM - 12:15 PM
The difference between planned and delivered dose for head and neck cancer, and the consequences for normal tissue toxicity probability
Poster Presenter:
Presentation No : MO_40_2526
10:45 AM - 12:15 PM
The Dose per Fraction as a Significant Prognostic Factor in Nasopharyngeal Carcinoma(NPC) Treated With Intensity Modulated Radiation Therapy(IMRT)
Poster Presenter:
Presentation No : MO_37_2871
10:45 AM - 12:15 PM
The Effect of Debulking Surgery on Brainstem Dosimetry and Toxicity for Large Vestibular Schwannomas Treated with Fractionated Stereotactic Radiation Therapy
Poster Presenter:
Presentation No : MO_9_2702
10:45 AM - 12:15 PM
The effect of low dose radiation on Alzheimer's disease-induced TG mice
Poster Presenter:
Presentation No : MO_2_2495
10:45 AM - 12:15 PM
The Efficacy and Safety of Raltitrexed-Cisplatin in Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma (LA-NPC)
Poster Presenter:
Presentation No : MO_35_2831
10:45 AM - 12:15 PM
The Feasibility of Deep Inspiration Breath-Hold in Children: Results of the TEDDI Pilot Study
Poster Presenter:
Presentation No : MO_42_2650
10:45 AM - 12:15 PM
The Impact of Adjuvant Radiation Therapy and Elective Nodal Irradiation in Early Stage/Low Grade versus Advanced Stage/High Grade Olfactory Neuroblastoma
Poster Presenter: – Ohio State University
Presentation No : MO_36_2842
10:45 AM - 12:15 PM
The Impact of Extra-Nodal Extension on Survival in Patients with HPV+ Oropharyngeal Squamous Cell Carcinoma Treated with Adjuvant Radiation Therapy
Poster Presenter: – Montefiore Medical Center
Presentation No : MO_31_2476
10:45 AM - 12:15 PM
The Impact of Image Guided Radiation Therapy for Nasopharyngeal Cancer Patients
Poster Presenter:
Presentation No : MO_33_2777
10:45 AM - 12:15 PM
The Impact of Low Skeletal Muscle Mass and Density on Patients with Head and Neck Cancer Receiving Concurrent Chemoradiation
Poster Presenter:
Presentation No : MO_39_2516
10:45 AM - 12:15 PM
The Impact of PET/CT Staging on the Incidence of Late Hodgkin Lymphoma Relapse for Patients Treated with Limited Radiation Fields
Poster Presenter:
Presentation No : MO_44_2512
10:45 AM - 12:15 PM
The Impact of Subclinical Regional Metastases on the Outcomes of Patients With Head and Neck Adenoid Cystic Carcinoma
Poster Presenter:
Presentation No : MO_40_2538
10:45 AM - 12:15 PM
The METABANK Score: A Clinical Tool to Predict Survival after Stereotactic Radiation Therapy for Oligometastatic Disease
Poster Presenter:
Presentation No : MO_19_2863
10:45 AM - 12:15 PM
The Prognostic Factors of Metastatic Nasopharyngeal Carcinoma at Initial Diagnosis:A Retrospective Analysis
Poster Presenter:
Presentation No : MO_38_2888
10:45 AM - 12:15 PM
The Prognostic Value of Pretreatment Neutrophil-to-lymphocyte Ratio in Hypopharyngeal Cancer Receiving Definitive Radiation Therapy
Poster Presenter:
Presentation No : MO_28_2657
10:45 AM - 12:15 PM
The Role of Dose-Escalation and Proton Therapy in Chondrosarcoma Treated with Perioperative Radiation Therapy or Definitive Radiation Therapy - An Analysis of the National Cancer Database
Poster Presenter:
Presentation No : MO_21_2749
10:45 AM - 12:15 PM
The Role of High B-Value Diffusion MRI in the Molecular Classification of Lower Grade Gliomas
Poster Presenter:
Presentation No : MO_12_2767
10:45 AM - 12:15 PM
The significant reduction of late Xerostomia of Intensity-modulated proton therapy for oropharyngeal cancer
Poster Presenter:
Presentation No : MO_36_2485
10:45 AM - 12:15 PM
The use of anti-PD1 therapy in melanoma patients with known brain metastases: Survival, durable intracranial progression free survival and radionecrosis
Poster Presenter:
Presentation No : MO_8_2644
10:45 AM - 12:15 PM
Time sequential changes of epithelial-mesenchymal transition signaling induced by ionizing radiation using next-generation sequencing in glioblastoma
Poster Presenter:
Presentation No : MO_7_2638
10:45 AM - 12:15 PM
Timing and Sequence of Chemoradiation for Low-Grade Gliomas Meeting RTOG 9802 Criteria
Poster Presenter:
Presentation No : MO_11_2730
10:45 AM - 12:15 PM
Total Marrow /Total Lymphoid Irradiation as conditioning for haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia patients
Poster Presenter:
Presentation No : MO_42_2474
10:45 AM - 12:15 PM
Total Skin Electron Irradiation and sequential malignancies in mycosis fungoides patients: Longitudinal study.
Poster Presenter:
Presentation No : MO_43_2779
10:45 AM - 12:15 PM
Toxicity and Local Control Outcomes for Brain Metastases Managed with Resection and Aggressive Reirradiation after Initial Radiosurgery Failure
Poster Presenter:
Presentation No : MO_6_2605
10:45 AM - 12:15 PM
Treatment Modality Choices and Outcome in Langerhans Cell Histiocytosis: Radiation Therapy Versus Other Modalities
Poster Presenter:
Presentation No : MO_42_2667
10:45 AM - 12:15 PM
Treatment of complex brain metastases with helical Tomotherapy: Results of a phase II trial
Poster Presenter:
Presentation No : MO_16_2879
10:45 AM - 12:15 PM
Treatment of Multiple Brain Metastases Using Single Isocentric Technique with Forward Planned Dynamic Arcs
Poster Presenter:
Presentation No : MO_6_2616
10:45 AM - 12:15 PM
Treatment Outcomes of Whole-Field vs. Split-Field Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma Patients
Poster Presenter:
Presentation No : MO_28_2663
10:45 AM - 12:15 PM
Treatment results of 61 cases of hypopharyngeal cancer with second primary esophageal cancer
Poster Presenter:
Presentation No : MO_38_2889
10:45 AM - 12:15 PM
Treatment-Induced Increase in Eosinophil Count is Associated With Improved Overall Survival in Glioblastoma patients
Poster Presenter:
Presentation No : MO_11_2737
10:45 AM - 12:15 PM
Trends in insurance coverage of proton therapy for Hodgkin lymphoma involving the thorax
Poster Presenter:
Presentation No : MO_18_2790
10:45 AM - 12:15 PM
Trends in Place of Death for Head and Neck Cancer Patients in the US from 1999 to 2016 Using the CDC WONDER Database
Poster Presenter:
Presentation No : MO_31_2740
10:45 AM - 12:15 PM
Tumor Cavity Recurrence after Stereotactic Radiosurgery of Surgically Resected Brain Metastases: Implication of Deviations from Contouring Guidelines
Poster Presenter:
Presentation No : MO_10_2710
10:45 AM - 12:15 PM
Tumor Infiltrating Lymphocytes May Predict for Distant Metastasis in Soft Tissue Sarcomas
Poster Presenter:
Presentation No : MO_20_2456
10:45 AM - 12:15 PM
Tumour Depth of Invasion vs Tumour Thickness in Determining Risk of Nodal Disease in Early Oral Tongue Squamous Cell Carcinoma
Poster Presenter:
Presentation No : MO_33_2776
10:45 AM - 12:15 PM
Two Versus Four Times-Weekly Accupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) for Treatment of Radiation-Induced Xerostomia: A Pilot Study
Poster Presenter:
Presentation No : MO_32_2756
10:45 AM - 12:15 PM
Uni or bilateral irradiation in cervical lymph node metastases of unknown primary?
Poster Presenter:
Presentation No : MO_37_2858
10:45 AM - 12:15 PM
Update of Comparison of Low-Dose and Standard-Dose Total Skin Electron Beam Therapy for Mycosis Fungoides
Poster Presenter:
Presentation No : MO_44_2501
10:45 AM - 12:15 PM
Use of 3-D Printed Custom Oral Stents to Improve Positioning and Reproducibility for Patients Treated for Head and Neck Cancer
Poster Presenter:
Presentation No : MO_33_2771
10:45 AM - 12:15 PM
Use of Radiation in High Risk Population with Non Melanoma Skin Cancer at a rural Cancer Center
Poster Presenter:
Presentation No : MO_29_2689
10:45 AM - 12:15 PM
Utility of an Intermediate Risk Volume in HPV+ Oropharyngeal Cancer: A Patterns of Failure Analysis.
Poster Presenter:
Presentation No : MO_38_2877
10:45 AM - 12:15 PM
Utilizing Organ-Sparing Marrow-Targeted Irradiation (OSMI) to Condition Patients with High-risk Hematologic Malignancies Prior to Allogeneic Hematopoietic Stem Cell Transplantation: Results from a Prospective Pilot Study
Poster Presenter:
Presentation No : MO_44_2865
10:45 AM - 12:15 PM
Validation and optimization of a web-based nomogram for predicting survival of patients with newly diagnosed glioblastoma
Poster Presenter:
Presentation No : MO_6_2622
10:45 AM - 12:15 PM
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From non-Endemic Areas in the Era of Intensity-Modulated Radiation Therapy
Poster Presenter:
Presentation No : MO_27_2647
10:45 AM - 12:15 PM
Value of Low Dose Bevacizumab in the Treatment of Radiation-induced Cerebral Necrosis for Patients with Nasopharyngeal Carcinoma
Poster Presenter:
Presentation No : MO_38_2891
10:45 AM - 12:15 PM
Value of Volumetric Staging and Hematologic Indices As an Alternative to the TNM Staging in Radiation Therapy for Tongue Cancer
Poster Presenter:
Presentation No : MO_30_2716
10:45 AM - 12:15 PM
Volumetric Changes in Retroperitoneal Sarcoma and the Implications for Adaptive Radiation Therapy Planning
Poster Presenter:
Presentation No : MO_20_2601
10:45 AM - 12:15 PM
Weekly Versus Triweekly Cisplatin in the Treatment of Patients With Head and Neck Cancer Receiving Concurrent Radiation Therapy
Poster Presenter:
Presentation No : MO_30_2719
10:45 AM - 12:15 PM
Whole-Brain Radiation Therapy Plus Sequential or Simultaneous Integrated Boost for the Treatment of Finite Number of Brain Metastases in Non-Small Cell Lung Cancer
Poster Presenter:
Presentation No : MO_14_2814
10:45 AM - 12:15 PM
Worse Survival in Older Adults with Rhabdomyosarcoma: Results of a Large Single Institutional Cohort
Poster Presenter:
Presentation No : MO_22_2797